(Q35128478)

6 August 2017

1 reference

title

Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation (English)

1 reference

6 August 2017

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

2 January 2024

1

David Bishop-Bailey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749590

2 January 2024

author name string

Jessica Wray

2

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12749590

2 January 2024

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0090698003000030?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

https://api.elsevier.com/content/article/PII:S0090698003000030?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

Prostaglandins and Other Lipid Mediators

2 January 2024

published in

1 reference

6 August 2017

71

1 reference

6 August 2017

1-2

1 reference

6 August 2017

1-22

1 reference

Peroxisome proliferator-activated receptors in the cardiovascular system

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPARs: transcription factors controlling lipid and lipoprotein metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator activated receptors and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPARS, metabolic disease and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptors in inflammation control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

A novel pathway of prostacyclin signaling-hanging out with nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPARs: transcriptional effectors of fatty acids and their derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Differential activation of adipogenesis by multiple PPAR isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome-proliferator-activated receptor delta mediates the effects of long-chain fatty acids on post-confluent cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Critical roles of PPAR beta/delta in keratinocyte response to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostacyclin-dependent apoptosis mediated by PPAR delta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Metabolic and additional vascular effects of thiazolidinediones.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPARgamma and atherosclerosis: effects on cell growth and movement

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Inflammatory pathways in atherosclerosis and acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Potential roles of the peroxisome proliferator-activated receptor-gamma in macrophage biology and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Controversy: PPARgamma as a target for treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Pluripotent PPARgamma polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR alpha and thyroid hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

1 reference

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Enzymes and receptors in the leukotriene cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Purification and characterisation of prostaglandin endoperoxide synthetase from sheep vesicular glands

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of Prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostaglandin and thromboxane biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostaglandin D2 and reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Function of prostanoid receptors: studies on knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Biological activities and mechanisms of action of PGJ2 and related compounds: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Induction of p53 and apoptosis by delta 12-PGJ2 in human hepatocarcinoma SK-HEP-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Inducible cyclooxygenase may have anti-inflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Regulated formation of eicosanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Nuclear localization of prostaglandin E2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Pharmacodynamic profile of prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Cytochrome P450 pathways of arachidonic acid metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Epoxygenase pathways of arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Role of CYP2E1 in the hepatotoxicity of acetaminophen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Epoxygenase metabolites. Epithelial and vascular actions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Cytochrome P450 metabolites of arachidonic acid in the control of renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2803%2900003-0

7 January 2021

Peroxisome proliferator-activated receptors (PPARs): from metabolic control to epidermal wound healing

27

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

Cyclo-oxygenase-2 in vascular smooth muscle

2 January 2024

46

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis

2 January 2024

49

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes

2 January 2024

84

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells

2 January 2024

105

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei

2 January 2024

109

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors

2 January 2024

129

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

20-HETE and the kidney: resolution of old problems and new beginnings

2 January 2024

133

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(03)00003-0

2 January 2024

Identifiers

1 reference

6 August 2017

1 reference